Enthera Pharmaceuticals Appoints Kazumi Shiosaki to Its Board of Directors and Lisa Olson to Its Scientific Advisory Board to Push Forward Company Growth and Development
The Pharma Data
DECEMBER 2, 2020
She is currently the CEO of Twentyeight-Seven, a biotech company focused on novel RNA biology that she co-founded alongside prominent Harvard investigators. Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. Kazumi holds a PhD in Synthetic Chemistry from UC Berkeley.
Let's personalize your content